Hypersplenism includes four treatment options: surgery, hormones such as prednisone combined with cytotoxic drugs such as cyclophosphamide, hormones combined with gammaglobulin, and antiviral drugs such as ganciclovir combined with hormones.
Hypersplenism is a syndrome of splenomegaly and decreased blood cells caused by various reasons. Common causes of hypersplenism include portal hypertension in cirrhosis, autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura, and infectious mononucleosis.
1. Surgical treatment: for patients with cirrhotic portal hypertension, splenectomy can be used to slow down the symptoms of hypersplenism by reducing or eliminating the high pressure.
2. Hormone and cytotoxic drug treatment: for patients with autoimmune anemia, glucocorticosteroids such as prednisone are mostly used, combined with immunosuppressant such as cyclophosphamide if necessary, plasma exchange and splenectomy can also be taken to slow down the symptoms of hypersplenism.
3. Hormone combined with gammaglobulin therapy: for patients with idiopathic thrombocytopenic purpura, glucocorticoid combined with high-dose gammaglobulin therapy is often used, and immunosuppressants such as azathioprine and cyclosporine A can be added to slow down the symptoms of hypersplenism if necessary.
4. Antiviral combined hormone therapy: For patients with infectious mononucleosis, antibiotics combined with antiviral drugs such as ganciclovir are often used to treat the disease, and glucocorticoids can be added when necessary to slow down the symptoms of hypersplenism.
It is recommended that patients with the above conditions go to a regular hospital in a timely manner and receive standardized treatment under the guidance of a doctor in order to avoid delays in their condition.